Search | Page 8 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)

    ... Myelodysplastic Syndrome (MDS): Primary or therapy related, including patients that will be considered for transplant. These ... Availability of appropriate, willing, HLA -matched related stem cell donor. Intervention:  ...

    Clinical Trial last updated 06/06/2016 - 10:28am.

  2. Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)

    ... bone marrow and kidney transplant from a partially matched related (haploidentical or "haplo") donor. This is a pilot study, you are being ...

    Clinical Trial last updated 05/09/2016 - 3:36pm.

  3. Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

    ... Patient's < or = 75 years old with a 5/6 or 6/6 related donor match are eligible. Patient's < or = 75 years who have a 7-8/8 HLA -A,B,C,DRB1 allele matched unrelated volunteer marrow and/or peripheral blood stem cell (PBSC) ...

    Clinical Trial last updated 05/02/2016 - 2:20pm.

  4. Intra-Osseous Co-Transplant of UCB and hMSC

    ... disease (e.g., myelodysplasia [MDS]) Treatment-related leukemia Complete remission (first complete remission [CR1]) with ... do not have human leukocyte antigen ( HLA )-matched (defined as matched in HLA A, B, C, and DRB1) related or unrelated ...

    Clinical Trial last updated 05/02/2016 - 11:15am.

  5. Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR

    ... an allogeneic hematopoietic stem cell transplantation from a related or unrelated HLA matched donor. The effect of 5-azacytidine on global gene methylation will ...

    Clinical Trial last updated 05/02/2016 - 11:10am.

  6. Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)

    ... bone marrow and kidney transplant from a partially matched related (haploidentical or "haplo") donor. This is a pilot study, you are being ...

    Clinical Trial last updated 04/27/2016 - 1:04pm.

  7. A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

    ... to historical OS rates in similar populations after RIC matched donor HSCT as reported in the literature. SECONDARY OBJECTIVES: I. To compare the treatment-related mortality (TRM) rate at 2 years for patients treated on this study to ...

    Clinical Trial last updated 04/27/2016 - 1:56pm.

  8. New York Blood Center National Cord Blood Program

    ... marrow transplantation but who do not have a suitable related bone marrow donor. Most patients are those with high risk of refractory leukemia, ... Cord Blood Transplantation Other Name: One or more matched umbilical cord blood units for transplant ...

    Clinical Trial last updated 04/27/2016 - 3:36pm.

  9. Nonmyeloablative Haploidentical Transplant Followed by MLN9708

    ... Availability of a 3/6 - 5/6 matched ( HLA -A, B, DR) related donor Donor must have negative HLA cross-match in the host vs. ...

    Clinical Trial last updated 04/29/2016 - 1:05pm.

  10. UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

    ... Status, and Graft Criteria <70 years of age with no matched 5/6 or 6/6 sibling donor - patients ≥ 70 and ≤ 75 years of age may ... based on IPSS or R-IPSS definitions; therapy-related MDS . Blasts must be < 5% by a representative bone marrow ...

    Clinical Trial last updated 04/29/2016 - 10:06am.